Health & Fitness
Mon, February 23, 2009Sun, February 22, 2009Fri, February 20, 2009Thu, February 19, 2009Wed, February 18, 2009Tue, February 17, 2009Mon, February 16, 2009Fri, February 13, 2009Thu, February 12, 2009Wed, February 11, 2009Tue, February 10, 2009Mon, February 9, 2009Sun, February 8, 2009Fri, February 6, 2009Thu, February 5, 2009Wed, February 4, 2009BioScrip to Host Fourth Quarter and Year-End 2008 Earnings Call
Published in Health and Fitness on Wednesday, February 11th 2009 at 10:03 GMT, Last Modified on 2009-02-11 10:04:10 by Market Wire
ELMSFORD, N.Y.--([ BUSINESS WIRE ])--BioScrip, Inc. (Nasdaq: BIOS) announced today that it will release its fourth quarter and year-end 2008 financial results before the market opens on Tuesday, March 3, 2009, and host a conference call shortly thereafter at 9:00 AM (Eastern Time) to discuss the results. Richard H. Friedman, Chairman and Chief Executive Officer, Stanley G. Rosenbaum, Executive Vice President and Chief Financial Officer, and Richard M. Smith, President and Chief Operating Officer, will host the call.
Interested parties may participate in the conference call by dialing 800-755-1805 (US), or 212-231-2901 (International), 5-10 minutes prior to the start of the call. A replay of the conference call will be available from 12:00 p.m. Eastern Time on Tuesday, March 3, through 12:00 p.m. Eastern Time on March 10, by dialing 800-633-8284 (US), or 402-977-9140 (International), and entering reservation #21414372. An audio web cast and archive of the conference call will also be available under the investor relations section of the BioScrip website at [ www.bioscrip.com ].
About BioScrip, Inc.
BioScrip, Inc. ([ www.bioscrip.com ]) (Nasdaq: BIOS) is a specialty pharmaceutical healthcare organization that partners with patients, physicians, healthcare payors and pharmaceutical manufacturers to provide access to medications and management solutions to optimize outcomes for chronic and other complex healthcare conditions.
Forward Looking Statements
This press release may contain statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company and our success with respect to the integration and consolidation. Investors are cautioned that any such forward looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission.
